Delivery Order SPE2DB22D1017-SPE2DB25FF0WY

Award Date 12/9/24
Potential Completion Date 12/10/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,398.52 firm fixed-price delivery order is for the product "PROGRAF 1 MG CAPSULE 100S" and has an ultimate completion date of October 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order (SPE2DB25FZ14B) valued at $25,634.40 for the supply of PROGRAF 1 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 20, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,326.84 and covers the delivery of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, through September 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,280.00 firm-fixed-price delivery order is for the supply of 4,565,815,730 units of the immunosuppressant drug Prograf 1 mg capsules. The contract has a period of performance through September 12, 2024 and does not utilize any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that provides a...
This federal contract award is a delivery order worth $1,589.62 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through October 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Prograf 1 mg capsules. The $3,280.00 firm fixed price contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Prograf 1 mg capsules, a medication used for organ transplant rejection prevention. The contract has a firm fixed price, with a ceiling value of $3,280 and a period of performance through November 12, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,252.35 firm fixed-price delivery order is for the supply of PROGRAF 5 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through May 28, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for Prograf 1 mg capsules. The contract has a ceiling value of $1,454.98 and is a firm fixed price contract type. The place of performance is Conshohocken, Pennsylvania. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $11,772.78 fixed-price contract is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a completion date of July 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF0WY
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,656.34, is for the delivery of 4566660639 Prograf 1 mg capsules. It is a firm fixed-price delivery order contract with a completion date of December 10, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 3/10/25, 9:51 AM